Levallois-Perret, France
Levallois-Perret, France

Time filter

Source Type

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Compression Therapy Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023" report to their offering. The global compression therapy market was worth USD 2.72 billion in 2015. Compression therapy involves wearing specially designed bandages, hosiery, socks or stockings, tapes for strengthening the support for veins and thereby increasing the blood circulation in the legs. Compression therapy materials apply gentle pressure to the ankles and legs. It helps in controlling the discomfort and swollening of legs. During the therapy, due to compression, muscular vibration is reduced significantly and delayed muscle soreness is prevented. Globally, the presence of large geriatric population with specific healthcare requirements related to venous or limb ailments is a prime factor that is anticipated to drive the growth of the compression therapy market. Increasing awareness about various venous diseases and injuries, along with the increase in participation in adventure and sporting activities are the major factors driving the growth of the compression therapy market. Compression pumps segment is expected to be the fastest growing segment in the global compression therapy market, due to the increasing number of patients with chronic illnesses related to limbs. The report segments the global compression therapy market by product, disease condition and region. The segmentation based on product includes compression pump, compression bandage, compression stocking and compression tape. On the basis of disease condition, the market is segmented as lymphedema, VTE and others. The companies covered in the report include 3M, BSN Medical GmbH, Medtronic PLC, SIGVARIS, Paul Hartmann AG, Bio Compression Systems, Inc, ArjoHuntleigh, Julius Zorn GmbH, Smith & Nephew PLC and Thuasne SA. For more information about this report visit http://www.researchandmarkets.com/research/496trh/compression


— Summary The global orthotics and prosthetics (O&P) market, which includes braces and supports and prosthetic devices, is an expansive market covering a broad range of indications. Braces and supports, external devices that provide support to joints and weakened musculoskeletal groups to facilitate function and healing, are utilized prominently in osteoarthritis management; fracture, sprain, strain, and tear treatment; and prophylactic sports use. For this report, prosthesis use is focused on a single indication: extremity amputation. The growing global aging population and subsequent rise in the prevalence of diseases that primarily affect the elderly, including diabetes, vascular disease, and osteoarthritis, as well as the increase in adoption of braces and supports for non-invasive treatment, particularly in fracture management and post-operative rehabilitation, are expected to drive growth in the O&P market. Emerging O&P technologies focus on improving patient comfort and functionality to facilitate increased product adoption. This report examines O&P device adoption and challenges faced by current competitors in the US. The analysis also identifies unmet needs in the market, specifies the major drivers and barriers to device adoption, and provides an understanding of physician perception and outlook with an overall emphasis on current and future industry trends in the US. Highlights Key Questions Answered - What is the current and future O&P market outlook in the US market? What trends are affecting this O&P market? - Which are the key, high growth markets that O&P manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment? - What are the unmet needs with O&P products currently on the market? How will emerging technologies fulfill these unmet needs? - What clinical factors and technical specifications influence a physician to use one type of brace or prosthetic device over another? What is physician perception and market outlook of O&P? - What are the challenges and complications of O&P that have hindered widespread adoption? - With developing the next-generation of O&P products, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global O&P market? Scope - Annualized total O&P market revenue by type of device, direct and indirect costs of disease, procedure trends, and market outlooks for the US through 2021. - Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in the US, and implications of the emerging technologies on the market. - Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and O&P products in development. - Analysis of the current and future market competition in the US O&P market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications. Reasons to buy - “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading orthopedic surgeons and O&P practitioners from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information. Table of Content: Key Points 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Catalyst 2.2 Related Reports 3 Industry Overview 3.1 Overview 3.2 Procedure Trends 3.2.1 US 3.3 Market Access 3.3.1 Purchasing Decisions 3.4 Brand Loyalty 3.5 Adoption 3.6 Regulation 3.7 Reimbursement 3.8 Product Recalls 3.8.1 Ability Dynamics Recalls Rush81 Prosthetic Foot (June 2014) 3.8.2 Zimmer Recalls Drop-Lok Knee Brace, Cartilage Knee Brace, Hinged Knee Support, and Tennis Elbow Support (April 2014) 3.8.3 Ossur Recalls Symbionic Leg (February 2014) 3.9 Mergers and Acquisitions 3.9.1 Ottobock Entered Licensing Agreement with Ekso Bionics (November 2014) 3.9.2 Breg to Merge with United Orthopedic Group (October 2014) 3.9.3 Ottobock to Distribute Artec’s 3D Scanners (July 2014) 3.9.4 Hanger Acquired Prosthetic Laboratories of Rochester (June 2014) 3.9.5 Hanger Acquired Four Patient Care Companies (August 2013) 3.9.6 Ossur Acquired TeamOlmed for $47m (May 2013) 3.9.7 DJO Global Acquired Exos (December 2012) 3.9.8 Hanger Acquired Two Patient Care Companies (December 2012) 3.9.9 Hanger Acquired Five Companies (August 2011) 3.9.10 Thuasne Acquired Townsend Design (January 2011) 3.10 Economic Impact 3.10.1 Indirect Costs 3.10.2 Direct Costs 4 Unmet Needs …Continued For more information, please visit http://www.wiseguyreports.com


— The Global Rollator Walker Market Research Report 2017 is a professional and in-depth study on the current state of the Rollator Walker industry. In the past five years from 2012 to 2016, global Rollator Walker production revenue market scale was from 19285 K USD to 27749 K USD. It is estimated to reach 29715 K USD by 2017 and 43354 K USD by 2022, with the CAGR of 8.85% in terms of revenue over the period 2017-2022. Companies profiled in this report are Graham-Field, Drive DeVilbiss Healthcare, Karman, Human Care, Meyra, Roscoe Medical, Kaiyang Medical Technology, Evolution Technologies, Dongfang, Briggs Healthcare, Matsunaga, Cardinal Health, Trionic Sverige, Handicare, Invacare, Thuasne, TOPRO, Access, Bischoff & Bischoff, HomCom and more. Analysis by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into • 3 Wheel Rollators • 4 Wheel Rollators • Others Analysis by Applications, this report focuses on consumption, market share and growth rate of Rollator Walker in each application, can be divided into • 65 to 85years Old • Above 85 Years Old • Young Population Table of Contents: 1 Rollator Walker Market Overview 2 Global Rollator Walker Market Competition by Manufacturers 3 Global Rollator Walker Production, Revenue (Value) by Regions (2012-2017) 4 Global Rollator Walker Supply (Production), Consumption, Export, Import by Regions (2012-2017) 5 Global Rollator Walker Production, Revenue (Value), Price Trend by Types 6 Global Rollator Walker Market Analysis by Applications 7 Rollator Walker Key Companies Analysis 8 Rollator Walker Manufacturing Cost Analysis 9 Industrial Chain, Sourcing Strategy and Downstream Buyers 10 Marketing Strategy Analysis, Distributors/Traders 11 Market Effect Factors Analysis 12 Global Rollator Walker Market Forecast (2017-2022) 13 Research Findings and Conclusion Inquire more about this report at: https://www.themarketreports.com/report/ask-your-query/445088 For more information, please visit https://www.themarketreports.com/report/global-rollator-walker-market-research-report-2017


News Article | November 23, 2016
Site: www.newsmaker.com.au

On the back of ageing population and spiked diabetic people bracket, the demand for ortho/diabetic shoes is projected to see a great demand in the region. The diabetic footwear market in United States was valued at USD 1112.0 Million in 2015 and it is anticipated that the market would increase at a healthy compound annual growth rate (CAGR) by 2021. The total population of diabetic patients in the U.S. has augmented from 5.5 million in 1982 to 22.0 million in 2014. Owing to this augmented growth of diabetic population, the risk of foot ulcers and neuropathy has also increased significantly in the previous few years. Diabetes is also one of the prominent causes of lower limb amputations in the U.S. At present, the U.S. is a home to around 2 million people surviving with amputations (limb losses) and according to an estimate around 185,010 limb losses occurs every year in the U.S. According to the Center for Disease Control and Prevention (CDC), it is estimated that one out of every three adults in the U.S. would suffer from diabetes by the end of 2050. With this rise in number of diabetic cases in the country, the risk of lower limb amputations would also soar in the future. In order to reduce the chances of amputations caused by diabetes, there is a great need of taking proper feet care measures like wearing right kind of footwear by the people. These measures and practices would surely help to fuel the market of diabetic footwear in the region. The therapeutic/diabetic footwear market in Canada is anticipated to witness a continuous rise in the year-on-year (y-o-y) growth rate from 4.6% in 2015 to 6.5% in 2017. However, the diabetic shoes demand growth rate is expected to decline by 0.8 percentage points from 7.09% in 2020 to 6.3% in 2021. The report studies the demand on the basis of inpatient and outpatient in the region which further has been granule to the country data. In addition to that, to understand the most profitable distribution mode in the region, the market for U.S., Canada & Mexico has been studied based on the online & offline channels. Offline distribution channels further have been studied into specialty store, clinics & street stores. Ø Which geography would have better demand for product/services? Ø What are the strategies adopted by big players in the regional market? Ø Which country would see the steep rise in CAGR & year-on-year (Y-O-Y) growth? Ø What is the current & expected market size in next five years? Ø What is the market feasibility for long term investment? Ø What opportunity the country would offer for existing and new players in the market? Ø What is risk involved for suppliers in the geography? Ø What factors would drive the demand for the product/service in near future? Ø What is the impact analysis of various factors in the market growth? Ø What are the recent trends in the regional market and how successful they are? 1. List of Figures& Tables 2. Executive Summary6 3. Market Entry & Winning Strategy 4. Research Methodology 5. Global Diabetic Footwear Market Size and Forecast 6. Market Segmentation     6.1 By Region       6.1.1 North America Market Size & Y-O-Y % growth, 2015-2021           6.1.1.1 U.S Market Size & Y-O-Y % growth, 2015-2021 6..1.1.1.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.1.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.1.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021           6.1.1.2 Canada Market Size & Y-O-Y % growth, 2015-2021 6..1.1.2.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.2.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.2.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021           6.1.1.3 Mexico Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021       6.1.2 Y-O-Y % Growth Comparison by Country       6.1.3 North America Base Point Scale (BPS) Analysis- By Demography       6.1.3 North America Base Point Scale (BPS) Analysis- By Inpatient & Outpatient       6.1.3 North America Base Point Scale (BPS) Analysis- By Retail Distribution       6.1.4 North America Market Attractiveness-By Country       6.1.4 North America Market Attractiveness-By Distribution Channel     6.2 North America Segmentation By Demography Market Size & Y-O-Y % growth, 2015-2021     6.3 North America By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021     6.4 North America By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021 7. Porter’s Five Force Model Analysis 9. Industry Growth Drivers     8.1 Rise in prevalence of diabetes in North America       8.1.1 Impact Analysis     8.2 Growth in the aging population       8.2.1 Impact Analysis     8.3 Increasing demand of customized diabetic footwear       8.3.1 Impact Analysis     8.4 Rise in spending on diabetes treatment       8.4.1 Impact Analysis 9. Restraints     9.1 High cost of diabetic footwea       9.1.1 Impact Analysis     9.2 Lack of awareness       9.2.1 Impact Analysis 10. Risk Analysis     10.1 Supply Risk - Medium     10.2 Demand Risk - Medium 11. Competitive Landscape     11.1 DARCO International Inc.       11.1.1 Company Overview       11.1.2 Products and Services       11.1.3 Key Financials       11.1.4 Recent News and Developments     11.2 Sigvaris       11.2.1 Company Overview       11.2.2 Products and services       11.2.3 Key Financials       11.2.4 Recent News and Developments     11.3 Ortho Europe       11.3.1 Company Overview       11.3.2 Products and Services       11.3.3 Key Financials       11.3.4 Recent news and developments     11.4 Duna Srl       11.4.1 Company Overview       11.4.2 Products and services       11.4.3 Key Financials       11.4.4 Recent News & Developments     11.5 Thuasne       11.5.1 Company Overview       11.5.2 Products and Services       11.5.3 Key Financials       11.5.4 Recent news & developments     11.6 Medline Industries       11.6.1 Company Overview       11.6.2 Products and services       11.6.3 Key Financials       11.6.4 Recent news & developments     11.7 DJO Global Inc       11.7.1 Company Overview       11.7.2 Products and services       11.7.3 Key Financials       11.7.4 Recent news & developments     11.8 Hong Kong Grace Shoes Development Co Ltd.       11.8.1 Company Overview       11.8.2 Products and services       11.8.3 Key Financials       11.8.4 Recent news & developments     11.9 Dr. Zen Inc       11.9.1 Company Overview       11.9.2 Products and services     11.9. 3 Key Financials       11.9.4 Recent news & developments     11.10 Supad       11.10.1 Company Overview       11.10.2 Products and services       11.10.3 Key Financials       11.10.4 Recent news & developments     11.11 Drew Shoe Corporation USA       11.11.1 Company Overview       11.11.2 Products and Services       11.11.3 Key Financials       11.11.4 Recent news & developments     11.12 Podartis Srl       11.12.1 Company Overview       11.12.2 Products and Services       11.12.3 Key Financials       11.12.4 Recent news & developments     11.13 Aetrex Worldwide, Inc.       11.13.1 Company overview       11.13.2 Products and Services       11.13.3 Key Financials       11.13.4 Recent news & developments Get It Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=695060


News Article | November 23, 2016
Site: www.newsmaker.com.au

The demand for the Diabetic shoes is on a continuous rise in the European region. In last few years, U.K. has recorded a significant increase in the prevalence of diabetes in the country. The number of diabetic population of the U.K. in 2013 was about 3 million with most of the countries like England and Scotland having significant percentage of diabetes prevalence. With an average prevalence rate of 6% in all the areas, it is anticipated that in future more people would get affected from diabetes in the U.K. and the total diabetic population of the country would expand to 5.1 million by 2025. U.K. is also witnessing a massive spurt in the total number of obese or overweight population over the past few years. Currently, around 68% of male population and 58% of female population of the state are suffering from obesity problems. It is anticipated that the obesity level would further increase in the state with 75% of males and 65% of females’ becoming obese by 2030. Germany has the lion’s share of healthcare spending among all European countries which accounts for 10.5% of its GDP. Around 26% of this spending is contributed on the improvement of diabetic treatment facilities in the country and with rising new cases of diabetes this spending is further expected to increase in future. Request a sample report @ https://www.wiseguyreports.com/sample-request/695059-europe-diabetic-shoes-footwear-market-demand-opportunity-outlook-2021 Thus, citing the above mentioned factors it could be anticipated that the diabetic footwear market of Germany would have more opportunities to flourish during the covered forecast period of 2015-2021. The report studies the demand and opportunities on the basis of inpatient and outpatient in the region which further has been granule to the country data. In addition to that, to understand the most profitable distribution mode in the region, the market for U.K., Germany, France, Italy, Spain, Hungary, Benelux has been studied based on the online & offline channels. Offline distribution channels further have been studied into specialty store, clinics & street stores. Key Answers Captured in Report? Ø Which geography would have better demand for product/services? Ø What are the strategies adopted by big players in the regional market? Ø Which country would see the steep rise in CAGR & year-on-year (Y-O-Y) growth? Ø What is the current & expected market size in next five years? Ø What is the market feasibility for long term investment? Ø What opportunity the country would offer for existing and new players in the market? Ø What is risk involved for suppliers in the geography? Ø What factors would drive the demand for the product/service in near future? Ø What is the impact analysis of various factors in the market growth? Ø What are the recent trends in the regional market and how successful they are? 1. List of Figures & Tables 2. Executive Summary 3. Market Entry & Winning Strategy 4. Research Methodology 5. Global Diabetic Footwear Market Size and Forecast 6. Market Segmentation     6.1 By Region       6.1.1 Europe Market Size & Y-O-Y % growth, 2015-2021           6.1.1.1 U.K. Market Size & Y-O-Y % growth, 2015-2021 6..1.1.1.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.1.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.1.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021           6.1.1.2 Germany Market Size & Y-O-Y % growth, 2015-2021 6..1.1.2.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.2.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.2.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021           6.1.1.3 France Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021           6.1.1.3 Spain Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021           6.1.1.3 Italy Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021           6.1.1.3 Hungarye Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021           6.1.1.3 Benelux Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021       6.1.2 Y-O-Y % Growth Comparison by Country       6.1.3 Europe Base Point Scale (BPS) Analysis- By Demography       6.1.3 Europe Base Point Scale (BPS) Analysis- By Inpatient & Outpatient       6.1.3 Europe Base Point Scale (BPS) Analysis- By Retail Distribution       6.1.4 Europe Market Attractiveness-By Country       6.1.4 Europe Market Attractiveness-By Distribution Channel     6.2 Europe Segmentation By Demography Market Size & Y-O-Y % growth, 2015-2021     6.3 Europe By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021     6.4 Europe By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021 7. Porter’s Five Force Model Analysis 9. Industry Growth Drivers     8.1 Rise in prevalence of diabetes in Europe       8.1.1 Impact Analysis     8.2 Growth in the aging population       8.2.1 Impact Analysis     8.3 Increasing demand of customized diabetic footwear       8.3.1 Impact Analysis     8.4 Rise in spending on diabetes treatment       8.4.1 Impact Analysis 9. Restraints     9.1 High cost of diabetic footwea       9.1.1 Impact Analysis     9.2 Lack of awareness       9.2.1 Impact Analysis 10. Risk Analysis     10.1 Supply Risk     10.2 Demand Risk 11. Competitive Landscape     11.1 DARCO International Inc.       11.1.1 Company Overview       11.1.2 Products and Services       11.1.3 Key Financials       11.1.4 Recent News and Developments     11.2 Sigvaris       11.2.1 Company Overview       11.2.2 Products and services       11.2.3 Key Financials       11.2.4 Recent News and Developments     11.3 Ortho Europe       11.3.1 Company Overview       11.3.2 Products and Services       11.3.3 Key Financials       11.3.4 Recent news and developments     11.4 Duna Srl       11.4.1 Company Overview       11.4.2 Products and services       11.4.3 Key Financials       11.4.4 Recent News & Developments     11.5 Thuasne       11.5.1 Company Overview       11.5.2 Products and Services       11.5.3 Key Financials       11.5.4 Recent news & developments     11.6 Medline Industries       11.6.1 Company Overview       11.6.2 Products and services       11.6.3 Key Financials       11.6.4 Recent news & developments     11.7 DJO Global Inc       11.7.1 Company Overview       11.7.2 Products and services       11.7.3 Key Financials       11.7.4 Recent news & developments     11.8 Hong Kong Grace Shoes Development Co Ltd.       11.8.1 Company Overview       11.8.2 Products and services       11.8.3 Key Financials       11.8.4 Recent news & developments     11.9 Dr. Zen Inc       11.9.1 Company Overview       11.9.2 Products and services     11.9. 3 Key Financials       11.9.4 Recent news & developments     11.10 Supad       11.10.1 Company Overview       11.10.2 Products and services       11.10.3 Key Financials       11.10.4 Recent news & developments     11.11 Drew Shoe Corporation USA       11.11.1 Company Overview       11.11.2 Products and Services       11.11.3 Key Financials       11.11.4 Recent news & developments     11.12 Podartis Srl       11.12.1 Company Overview       11.12.2 Products and Services       11.12.3 Key Financials       11.12.4 Recent news & developments     11.13 Aetrex Worldwide, Inc.       11.13.1 Company overview       11.13.2 Products and Services       11.13.3 Key Financials       11.13.4 Recent news & developments Disclaimer Get It Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=695059


News Article | November 23, 2016
Site: www.newsmaker.com.au

Diabetes is a prolonged medical condition, which is caused by low levels of insulin in the body. A person suffering from diabetes is more prone to develop wounds, ulcers or lack of sensation in any part of his body, particularly in his feet. Diabetic/therapeutic shoes have evolved as a medical revolution as it aids in preventing the feet of a diabetic person from developing any injuries or wounds with the help of its unique design and therapeutic properties. The global market of diabetic footwear is currently valued at around USD 15044 Million and is anticipated to flourish at a healthy compound annual growth rate (CAGR) of 8.27% during the forecast period i.e. 2015-2021. The global diabetic/therapeutic footwear market would majorly be driven by the rising prevalence of diabetes (in 20-79 years of age group) in the world. Apart from rising prevalence of diabetes, rise in spending on diabetes treatment is yet another major growth driver of the diabetic footwear market. The global spending on diabetes is projected to expand from USD 936 Billion in 2015 to USD 1,128 Billion by 2021. This rise in spending would definitely help the global diabetic footwear market in the coming 8-10 years of time. Regionally, Asia Pacific region is anticipated to witness the highest growth in the diabetic footwear market, with China being the largest market in the region followed by India during the forecast period i.e. 2015-2021. Growth in the aging population, strengthening economic condition, better GDP figures and increase in the per capita income are some of the major factors that would escalate the demand of diabetic footwear in the Asia Pacific region. The global diabetic footwear market is segmented on the basis of demography, which depicts that women have higher tendency to purchase the diabetic footwear than men. Owing to this tendency, the female diabetic footwear (68% share in 2014), occupies the largest market of diabetic footwear across the globe. However, owing to an increase in the total number of male diabetic patients in comparison to female diabetic patients in the world, there is a greater need of male diabetic footwear in the future. In addition to demography, the market is also segmented by inpatients and outpatients and by retail distribution. The retail distribution is further segmented into on-line and off-line retail out of which, the on-line distribution channel is anticipated to have the largest share by 2021. The major reason behind the growth of e-commerce channels can be attributed to rising penetration of smartphones and high speed internet services like 3G and 4G in the world. In contrast, lack of awareness regarding proper feet care in diabetic patients and lack of knowledge in terms of use of diabetic footwear is one of the major obstacles that hinder the growth of the diabetic footwear market across the globe. DARCO International, Ortho Europe, Duna Srl, Thuasne, DJ Global, Hong Kong Grace Shoes, Dr. Zen Inc., Drew Shoe Corporation, and Podartis Srl are some of the major key players of the global diabetic footwear market. 1. List of Figures 2. List of Tables 3. Executive Summary 4. Research Methodology 5. Global Diabetic Footwear Market Size and Forecast 6. Market Segmentation     6.1 By Regions       6.1.1 North America           6.1.1.1 U.S.           6.1.1.2 Canada           6.1.1.3 Mexico           6.1.1.4 Market Attractiveness of North America           6.1.1.5 BPS Analysis of North America       6.1.2 Europe           6.1.2.1 U.K.           6.1.2.2 Germany           6.1.2.3 France           6.1.2.4 Spain           6.1.2.5 Italy           6.1.2.6 Hungary           6.1.2.7 Benelux (Belgium, Netherlands and Luxembourg)           6.1.2.8 Market Attractiveness of Europe           6.1.2.9 BPS Analysis of Europe       6.1.3 Russia       6.1.4 Asia Pacific           6.1.4.1 India           6.1.4.2 China           6.1.4.3 Singapore           6.1.4.4 Japan           6.1.4.5 Market Attractiveness of Asia-Pacific           6.1.4.6 BPS Analysis of Asia Pacific       6.1.5 MENA       6.1.6 Latin America       6.1.7 Oceanic           6.1.7.1 Australia           6.1.7.2 New Zealand           6.1.7.3 Market Attractiveness of Oceanic region           6.1.7.4 BPS Analysis of Oceanic Region     6.2 By Demography     6.3 By Inpatient and Outpatient     6.4 By Retail Distribution 7. Porter’s Five Force Model Analysis 8. Industry Growth Drivers     8.1 Rise in prevalence of diabetes in the world       8.1.1 Impact Analysis     8.2 Growth in the aging population       8.2.1 Impact Analysis     8.3 Increasing demand of customized diabetic footwear       8.3.1 Impact Analysis     8.4 Rise in spending on diabetes treatment       8.4.1 Impact Analysis 9. Restraints     9.1 High cost of diabetic footwear       9.1.1 Impact Analysis     9.2 Lack of awareness       9.2.1 Impact Analysis 10. Risk Analysis     10.1 Supply Risk - Medium     10.2 Demand Risk - Medium 11. Competitive Landscape     11.1 DARCO International Inc.       11.1.1 Company Overview       11.1.2 Products and Services       11.1.3 Key Financials       11.1.4 Recent News and Developments     11.2 Sigvaris       11.2.1 Company Overview       11.2.2 Products and services       11.2.3 Key Financials       11.2.4 Recent News and Developments     11.3 Ortho Europe       11.3.1 Company Overview       11.3.2 Products and Services       11.3.3 Key Financials       11.3.4 Recent news and developments     11.4 Duna Srl       11.4.1 Company Overview       11.4.2 Products and services       11.4.3 Key Financials       11.4.4 Recent News & Developments     11.5 Thuasne       11.5.1 Company Overview       11.5.2 Products and Services       11.5.3 Key Financials       11.5.4 Recent news & developments     11.6 Medline Industries       11.6.1 Company Overview       11.6.2 Products and services       11.6.3 Key Financials       11.6.4 Recent news & Developments     11.7 DJ Global Inc.       11.7.1 Company Overview       11.7.2 Products and services       11.7.3 Key Financials       11.7.4 Recent news & developments     11.8 Hong Kong Grace Shoes Development Co Ltd.       11.8.1 Company Overview       11.8.2 Products and services       11.8.3 Key Financials       11.8.4 Recent news & developments     11.9 Dr. Zen Inc.       11.9.1 Company Overview       11.9.2 Products and services       11.9.3 Key Financials       11.9.4 Recent news & developments     11.10 Supad       11.10.1 Company Overview       11.10.2 Products and services       11.10.3 Key Financials       11.10.4 Recent news & developments     11.11 Drew Shoe Corporation USA       11.11.1 Company Overview       11.11.2 Products and Services       11.11.3 Key Financials       11.11.4 Recent news & Developments     11.12 Podartis Srl       11.12.1 Company Overview       11.12.2 Products and Services       11.12.3 Key Financials       11.12.4 Recent news & developments     11.13 Aetrex Worldwide, Inc.       11.13.1 Company overview       11.13.2 Products and Services       11.13.3 Key Financials       11.13.4 Recent news & developments Get It Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=490493


Global OTC orthopedic braces market is segmented into lower extremity braces (knee and foot & ankle braces), upper extremity braces (shoulder, elbow, and wrist braces), back & hip braces, and other braces (neck, groin, calf, thigh, and facial braces). Lower extremity braces segment is expected to grow at highest CAGR in next five years, owing to growing geriatric population (coupled with the higher prevalence of knee arthritis among geriatrics as compared to adult individuals), high adoption of knee braces among athletes, rising number of knee replacement surgeries, growing prevalence of obesity, and significant demand for noninvasive treatments across the globe. Complete report on OTC orthopedic braces market spread across 306 Pages, Profiling 11 Companies and Supported with 58 tables and 15 figures is now available at http://www.rnrmarketresearch.com/otc-orthopedic-braces-market-by-product-otc-back-brace-otc-knee-brace-otc-ankle-brace-foot-walkers-shoulder-braces-elbow-braces-indication-prophylactic-injury-osteoarthritis-geography-north-america-eu-st-to-2021-market-report.html . Factors such as the growing demand for OTC orthopedic braces market among the geriatric population, rising incidence of bone-degenerative diseases, increasing global burden for obesity, ongoing commercialization of orthopedic bracing and support products, affordability and easy availability of OTC orthopedic brace (as compared to prescription-based products), rising public participation in sports, easy accessibility of OTC orthopedic brace and supports through e-commerce websites, and adoption of orthopedic braces for preventive care are propelling the growth of the global market. Emerging markets (including China, India, and Brazil) are expected to offer significant growth opportunities for players active in the OTC orthopedic braces market. The growing middle-class population, increasing GDP and healthcare expenditure among emerging Asian countries, and increasing public awareness about various treatment options available for orthopedic conditions are the key factors propelling the demand of OTC orthopedic braces and supports in the emerging nations. Hence, players are expanding their presence in these countries in order to leverage the high growth opportunities. Interested in this report, Report copy of this research is available now Geographically, North America is estimated to command the largest share of the global OTC orthopedic braces market in 2016, followed by Europe. The large share of the North American region can be attributed to the rising geriatric population, increasing incidence of osteoporosis and osteoarthritis, growing obese population, rising number of injuries due to road accidents, and active participation of the population in sporting activities. DJO Finance LLC (U.S.), DeRoyal Industries Inc. (U.S.), Breg, Inc. (U.S.), Össur hf. (Iceland), Bauerfeind AG (Germany), BSN Medical (Germany), Otto Bock HealthCare (Germany), medi GmbH & Co. KG (Germany), Thuasne Group (France), and 3M Company (U.S.). Click now for more Details, Queries and Discount and Other Information on this study “OTC Orthopedic Braces Market by Product (OTC Back Brace, OTC Knee Brace, OTC Ankle Brace, Foot Walkers, Shoulder Braces, Elbow Braces), Indication (Prophylactic, Injury, Osteoarthritis), Geography (North America, Europe, Asia, Oceania) - Global Forecast to 2021” research report can be requested at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=735230 . In this report, OTC orthopedic braces market has been segmented by product, indication, and region. From an insight perspective, this research report focuses on various levels of analysis - market share analysis of top players & company profiles, which together comprise & discuss basic views on the competitive landscape; emerging & high-growth segments of OTC orthopedic braces market ;and high-growth regions & their respective drivers, restraints,challenges & opportunities. However, limited medical reimbursements and availability of innovative alternative treatment options in the North American region are negatively affecting the growth of the OTC orthopedic braces market in this region. Browser more report on medical devices at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices .


A device (1) includes a first web of soft material (5), a projecting structure integral with the web and including multiple discrete projecting elements. The projecting elements include pieces of foam (3) spaced apart form one another and integral with the first web (5). The pieces of foam are compressed between the first web (5) and a second web (7) of soft material, the two webs mutually adhering between the projecting elements. The device is useful for treating various types of edemas and excessive tissue infiltration, as well as for repairing sports injury.


The object of the present invention is a method for manufacturing a tubular compression item (1), having at least one leg part (2), one foot tip (3), one heel (4) and one foot (5), comprising a first step for knitting the leg part (2) and the foot (5) with at least one mesh thread (7) on a twin cylinder knitting machine during which an elastic weft thread (8) is inserted between two rows of ribbed stitches (n)*(p) and (n)*(p) every 1/1 to 1/5 rows of stitches of the leg part (2) and of the foot (5), on at least 50% by number of the number (m) of needles without forming any tuck stitch or loop stitch.


Patent
Thuasne | Date: 2011-02-09

The invention relates to a tubular compressive orthosis having an upper edge defining a first knitted compression zone, and comprising, close to said upper edge, at least one grip element facilitating the process of putting on the orthosis. Characteristically, the grip element is a second knitted gripping zone arranged beneath the upper edge and having a mesh density higher than the mesh density of the first compression zone.

Loading Thuasne collaborators
Loading Thuasne collaborators